A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection

Clinical Infectious Diseases

Volumn 41, Issue 9, 2005, Pages 1261-1268

  Gessner, Bradford O ^a,d   Bruce, Michael G ^b   Parkinson, Alan J ^b   Gold, Benjamin D ^c   Muth, Pam T ^a   Dunaway, Eitel ^b   Baggett, Henry C ^a  

^a Alaska Division of Public Health   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Alaska Section Epidemiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH SALICYLATE; CLARITHROMYCIN; FERROUS SULFATE; LANSOPRAZOLE; MACROLIDE; METRONIDAZOLE;

ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHOOL CHILD; SCREENING; TREATMENT FAILURE; UNITED STATES; UREA BREATH TEST;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHILD; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; OMEPRAZOLE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 27444442648     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/496925     Document Type: Article

References (44)

1. Gold BD, Colletti RB, Abbott M, et al. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000; 31:490-7.
2. Oderda G, Marinello D, Lerro P, et al. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. Helicobacter 2004; 9:293-301.
3. Dohil R, Israel DM, Hassall E. Effective 2-wk therapy for Helicobacter pylori disease in children. Am J Gastroenterol 1997; 92:244-7.
4. Shamaly H, Berkowitz D, Rosenthal E, Naveh Y. Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis. J Pediatr Gastroenterol Nutr 2000; 30:198-200.
5. Moshkowitz M, Reif S, Brill S, et al. One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents. Pediatrics 1998; 102:e14.
6. Behrens R, Lang T, Keller KM, et al. Dual versus triple therapy of Helicobacter pylori infection; results of a multicentre trial. Arch Dis Child 1999; 81:68-70.
7. Shashidhar H, Peters J, Lin CH, Rabah R, Thomas R, Tolia V. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 2000; 30:275-82.
8. Kato S, Takeyama J, Ebina K, Naganuma H, Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children. Pediatrics 1997; 100:e3.
9. Casswall TH, Alfven G, Drapinski M, Bergstrom M, Dahlstrom KA. One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 1998; 27:415-3.
10. Tiren U, Sandstedt B, Finkel Y. Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole. Acta Paediatr 1999; 88:166-8.
11. Kato S, Ritsuno H, Ohnuma K, Iinuma K, Sugiyama T, Asaka M. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. Helicobacter 1998; 3:278-82.
12. Gottrand F, Kalach N, Spyckerelle C, et al. Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: a prospective randomized double-blind trial. J Pediatr 2001; 139:664-8.
13. Ashorn M, Rago T, Kokkonen J, Ruuska T, Rautelin H, Karikosld R. Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: double blind randomized placebo-controlled trial. J Clin Gastroenterol 2004; 38:646-50.
14. Tindberg Y, Casswall TH, Blennow M, Bengtsson C, Granstrom M, Sorberg M. Helicobacter pylori eradication in children and adolescents by a once daily 6-day treatment with or without a proton pump inhibitor in a double-blind randomized trial. Aliment Pharmacol Ther 2004; 20: 295-302.
15. Wewer V, Andersen LP, Paerregaard A, et al. Treatment of Helicobacter pylori in children with recurrent abdominal pain. Helicobacter 2001; 6: 244-8.
16. Torres I, Perez-Perez G, Goodman KJ, et al. A comprehensive review of the natural history of Helicobacter pylori infection in children. Arch Med Res 2000; 31:431-69.
17. Parkinson AJ, Gold BD, Bulkow L, et al. High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol 2000; 7:885-8.
18. Sherman P, Hassall E, Hunt RH, et al. Canadian Helicobacter Study Group consensus conference on the approach to Helicobacter pylori infection in children and adolescents. Can J Gastroenterol 1999; 13:553-9.
19. Drumm B, Koletzko S, Oderda G. Helicobacter pylori infection in children: a consensus statement. European Paediatric Task Force on Helicobacter pylori. J Pediatr Gastroenterol Nutr 2000; 30:207-13.
20. Kato S, Nakayama K, Minoura T, et al. Comparison between the 13C-urea breath test and stool antigen test for the diagnosis of childhood Helicobacter pylori infection. J Gastroenterol 2004; 39:1045-50.
21. Hino B, Eliakim R, Levine A, et al. Comparison of invasive and non-invasive tests diagnosis and monitoring of Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr 2004; 39:519-23.
22. Yip R, Limburg PJ, Ahlquist DA, et al. Pervasive occult gastrointestinal bleeding in an Alaska Native population with prevalent iron deficiency: role of Helicobacter pylori gastritis. JAMA 1997; 277:1135-9.
23. Choe YH, Kim SK, Son BK, Lee DH, Hong YC, Pai SH. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter 1999; 4:135-9.
24. Petersen KM, Parkinson AJ, Nobmann ED, Bulkow L, Yip R, Mokdad A. Iron deficiency anemia among Alaska Natives may be due to fecal loss rather than inadequate intake. J Nutr 1996; 126:2774-83.
25. Centers for Disease Control and Prevention. Iron deficiency anemia in Alaskan Native children-Hooper Bay, Alaska, 1999. MMWR Morb Mortal Wkly Rep 1999; 48:714-6.
26. Rodrigues MN, Queiroz DM, Bezerra Filho JG, Pontes LK, Rodrigues RT, Braga LL. Prevalence of Helicobacter pylori infection in children from an urban community in north-east Brazil and risk factors for infection. Eur J Gastroenterol Hepatol 2004; 16:201-5.
27. Goodman KJ, Correa P, Tengana Aux HJ, et al. Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. Am J Epidemiol 1996; 144:290-9.
28. Castro Lde P, Coelho LG. Helicobacter pylori in South America. Can J Gastroenterol 1998; 12:509-12.
29. Nabwera HM, Nguyen-Van-Tam JS, Logan RF, Logan RP. Prevalence of Helicobacter pylori infection in Kenyan schoolchildren aged 3-15 years and risk factors for infection. Eur J Gastroenterol Hepatol 2000; 12:483-7.
30. Sarker SA, Mahalanabis D, Hildebrand P, et al. Helicobacter pylori: prevalence, transmission, and serum pepsinogen 11 concentrations in children of a poor periurban community in Bangladesh. Clin Infect Dis 1997; 25: 990-5.
31. Raymond J, Kalach N, Bergeret M, et al. Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children. Antimicrob Agents Chemother 1998; 42:1334-5.
32. Wermeille J, Cunningham M, Dederding JP, et al. Failure of Helicobacter pylori eradication: is poor compliance the main cause? Gastroenterol Clin Biol 2002; 26:216-9.
33. Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 2003; 17:99-109.
34. McMahon BJ, Hennessy TW, Bensler JM, et al. The relationship among previous antimicrobial use, antimicrobial resistance and treatment outcomes for Helicobacter pylori infections. Ann Intern Med 2003; 139:463-9.
35. Fallone CA, Loo V, Joseph L, Barkun J, Kostyk R, Barkun AN. Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial. Clin Invest Med 1999; 22:185-94.
36. Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUADRATE study. Gastroenterology 2002; 123:1763-9.
37. van der Hulst RW, van der Ende A, Homan A, Roorda P, Dankert J, Tytgat GN. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut 1998; 42:166-9.
38. Faber J, Bar-Meir M, Rudensky B, et al. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful? J Pediatr Gastroenterol Nutr 2005; 40:571-4.
39. Clemens J, Albert MJ, Rao M, et al. Sociodemographic, hygienic and nutritional correlates of Helicobacter pylori infection of young Bangladeshi children. Pediatr Infect Dis J 1996; 15:1113-8.
40. Wizla-Derambure N, Michaud L, Ategbo S, et al. Familial and community environmental risk factors for Helicobacter pylori infection in children and adolescents. J Pediatr Gastroenterol Nutr 2001; 33:58-63.
41. McCallion WA, Murray LJ, Bailie AG, Dalzell AM, O'Reilly DP, Bamford KB. Helicobacter pylori infection in children; relation with current house-hold living conditions. Gut 1996; 39:18-21.
42. Webb PM, Knight T, Greaves S, et al. Relation between infection with Helicobacter pylori and living conditions in childhood: evidence for person to person transmission in early life. BMJ 1994; 308:750-3.
43. Malaty HM, Logan ND, Graham DY, Ramchatesingh JE. Helicobacter pylori infection in preschool and school-aged minority children: effect of socioeconomic indicators and breast-feeding practices. Clin Infect Dis 2001; 32:1387-92.
44. Sinha SK, Martin B, Sargent M, McConnell JP, Bernstein CN. Age at acquisition of Helicobacter pylori in a pediatric Canadian First Nations population. Helicobacter 2002; 7:76-85.